COPD

Dupilumab is the first investigational biologic to significantly improve lung function in COPD patients

by

Dupilumab (Dupixent; Sanofi) is the first and only investigational biologic to significantly improve lung function at 12 and 52 weeks and significantly reduce severe acute exacerbations compared with placebo in adults with chronic obstructive pulmonary disease (COPD), according to the authors. presented a positive Phase 3 best outcome at the 2023 American Thoracic Society (ATS) … Read more

Study: Smoking weed not linked to COPD

by

Marijuana smoking is not associated with chronic obstructive pulmonary disease, or COPD, according to a newly released study. Researchers at the University of California, Los Angeles looked at participants who smoke or have smoked tobacco cigarettes and divided them into three groups: current, former, or never smokers. The study authors said limited data are available … Read more